CATHERINE GOETZ: Open Payments
NPI 1770507808 · OLEY, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,319 in 65 payments from 18 companies in 2025. Trend: 2023 $801 · 2024 $1,264 · 2025 $1,319
Food & beverage: $1,319
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $270 |
| AstraZeneca Pharmaceuticals LP | 7 | $151 |
| ABBVIE INC. | 13 | $142 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $107 |
| Otsuka America Pharmaceutical, Inc. | 5 | $106 |
| PFIZER INC. | 4 | $91 |
| Novartis Pharmaceuticals Corporation | 3 | $63 |
| Lilly USA, LLC | 3 | $59 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $59 |
| Verona Pharma, Inc. | 3 | $55 |
Products named: Ozempic, JARDIANCE, REXULTI, AIRSUPRA, UBRELVY, QULIPTA, Kerendia, NURTEC ODT.
Industry payments across PA — which companies pay providers there.
